Biovica Financial Statements From 2010 to 2025
| BIOVIC-B | SEK 0.83 0.17 17.00% |
Check Biovica International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovica International's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biovica financial statements analysis is a perfect complement when working with Biovica International Valuation or Volatility modules.
Biovica |
Biovica International AB Company Current Valuation Analysis
Biovica International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biovica International Current Valuation | 175.91 M |
Most of Biovica International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biovica International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Biovica International AB has a Current Valuation of 175.91 M. This is 98.78% lower than that of the Healthcare sector and 96.21% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 98.94% higher than that of the company.
Biovica International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biovica International's current stock value. Our valuation model uses many indicators to compare Biovica International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biovica International competition to find correlations between indicators driving Biovica International's intrinsic value. More Info.Biovica International AB is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biovica International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biovica International's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biovica International Financial Statements
Biovica International stakeholders use historical fundamental indicators, such as Biovica International's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biovica International investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biovica International's assets and liabilities are reflected in the revenues and expenses on Biovica International's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biovica International AB. Please read more on our technical analysis and fundamental analysis pages.
Biovica International AB , a biotech company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. Biovica International AB was founded in 2009 and is based in Uppsala, Sweden. Biovica International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biovica Stock
Biovica International financial ratios help investors to determine whether Biovica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovica with respect to the benefits of owning Biovica International security.